(Q38432430)
Statements
1 reference
KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer (English)
1 reference
Ignacio I Wistuba
1 reference
Roy S Herbst
1 reference
Erminia Massarelli
1 reference
Marileila Varella-Garcia
1 reference
Ximing Tang
1 reference
Ana C Xavier
1 reference
Natalie C Ozburn
1 reference
Diane D Liu
1 reference
Benjamin N Bekele
1 reference
1 May 2007
1 reference
1 reference
13
1 reference
10
1 reference
2890-2896
1 reference
Identifiers
1 reference
1 reference